HIV can enter the CNS during acute infection. However, virus replication appears to be controlled since HIV-associated dementia generally does not develop until the onset of AIDS. The goals of these studies are to elucidate glial cell inflammatory mechanisms that regulate HIV/SIV replication in the CNS. Using a SIV/macaque model of HIV dementia in which over 90% of infected animals develop encephalitis and all develop AIDS by 3 months, we demonstrated that during acute infection, virus replication in the brain is accompanied by enhanced expression of glial cell activation markers. Suppressed expression of glial activation markers and downregulation of viral RNA (to undetectable levels) occurred in parallel with increased expression of IFNbeta in the brain from acute through asymptomatic infection, despite continued virus replication in the periphery during this time. Because viral DNA levels in the brain remained constant from acute through asymptomatic infection, these findings suggest that non-cytolytic mechanisms involving glial cell activation and production of IFNbeta mediated downregulation of acute HIV/SIV gene expression. IFNbeta has been shown to inhibit ongoing HIV replication in macrophages but not lymphocytes, via transcriptional mechanisms involving expression of a dominant-negative isoform of the transcription factor C/EBPbeta. In addition to suppressing virus replication at a transcriptional level, IFNbeta may also inhibit post-transcriptional events required for viral gene expression by upregulating expression of PML (promyelocytic leukemia protein). During late stage infection of the CNS, resurgent virus replication occurs in the presence of both IFNbeta and enhanced expression of glial cell activation markers, and is accompanied by marked apoptosis, increased expression of neurodegenerative markers and development of encephalitis. Analysis of signaling pathways activated in glial cells during SIV infection revealed that acute infection is associated with activation of anti-apoptotic kinases (ERK) while late stage infection is associated with activation of pro-apoptotic/neurodegenerative kinases (JNK/p38). Thus, we hypothesize that activation of specific inflammatory pathways in glial cells differentially modulates IFNbeta-mediated antiviral mechanisms and hence, SIV replication.
Aim 1 will determine the level of transcriptional suppression during SIV infection of the CNS.
Aim 2 will identify cell-types producing and responding to IFNbeta and examine expression of specific C/EBP isoforms as well as expression and cellular distribution of PML.
Aim 3 will identify specific sites in the LTR occupied by transcription factors expressed longitudinally during SIV infection in the CNS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS047984-04
Application #
7217956
Study Section
AIDS Immunology and Pathogenesis Study Section (AIP)
Program Officer
Wong, May
Project Start
2004-03-01
Project End
2009-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
4
Fiscal Year
2007
Total Cost
$358,502
Indirect Cost
Name
Johns Hopkins University
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sisk, Jeanne M; Witwer, Kenneth W; Tarwater, Patrick M et al. (2013) SIV replication is directly downregulated by four antiviral miRNAs. Retrovirology 10:95
Ravimohan, Shruthi; Gama, Lucio; Engle, Elizabeth L et al. (2012) Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity. PLoS One 7:e42801
Zaritsky, Luna Alammar; Gama, Lucio; Clements, Janice E (2012) Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2. J Immunol 188:3876-85
Alammar, Luna; Gama, Lucio; Clements, Janice E (2011) Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol 186:4008-18
Page, Stephen H; Wright Jr, Edward K; Gama, Lucio et al. (2011) Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One 6:e22052
Co, Juliene G; Witwer, Kenneth W; Gama, Lucio et al. (2011) Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. J Infect Dis 204:1104-14
Ravimohan, Shruthi; Gama, Lucio; Barber, Sheila A et al. (2010) Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression. J Biol Chem 285:2258-73
Akhtar, Lisa Nowoslawski; Qin, Hongwei; Muldowney, Michelle T et al. (2010) Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 185:2393-404
Witwer, Kenneth W; Gama, Lucio; Li, Ming et al. (2009) Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 4:e8129
Mankowski, Joseph L; Queen, Suzanne E; Fernandez, Caroline S et al. (2008) Natural host genetic resistance to lentiviral CNS disease: a neuroprotective MHC class I allele in SIV-infected macaques. PLoS One 3:e3603

Showing the most recent 10 out of 24 publications